The biologically active isomers of conjugated linoleic acid.
Numerous physiological effects are attributed to conjugated linoleic acid (CLA). The purpose of this presentation is to consider these effects with respect to the cis-9,trans-11 and trans-10,cis-12 CLA isomers. We review previously published data and present new findings that relate to underlying biochemical mechanisms of action. Both isomers are natural products. The cis-9,trans-11 isomer is the principal dietary form of CLA, but the concentrations of this isomer and the trans-10,cis-12 isomer in dairy products or beef vary depending on the diet fed to cows or steers, respectively. The trans-10,cis-12 CLA isomer exerts specific effects on adipocytes, in particular reducing the uptake of lipid by inhibiting the activities of lipoprotein lipase and stearoyl-CoA desaturase. The trans-10,cis-12 CLA isomer also affects lipid metabolism in cultured Hep-G2 human liver cells, whereas both the cis-9,trans-11 and trans-10,cis-12 CLA isomers appear to be active in inhibiting carcinogenesis in animal models. We present new findings indicating that the cis-9,trans-11 CLA isomer enhances growth and probably feed efficiency in young rodents. Accordingly, the effects of CLA on body composition (induced by trans-10,cis-12 CLA) and growth/feed efficiency (induced by cis-9,trans-11 CLA) appear to be due to separate biochemical mechanisms. We also show that a 19-carbon CLA cognate (conjugated nonadecadienoic acid, CNA) inhibits lipoprotein lipase activity as effectively as CLA in cultured 3T3-L1 adipocytes. Presumably, CNA is metabolized differently than the 18-carbon CLA isomers, so this finding indicates direct activity of the administered compound as opposed to acting via a metabolite.
Pariza
M W
MW
Department of Food Microbiology and Toxicology, Food Research Institute, University of Wisconsin-Madison, 53706, USA. mwpariza@facstaff.wisc.edu
Park
Y
Y
Cook
M E
ME
D017667:Adipocytes / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002417:Cattle; D003611:Dairy Products; D006801:Humans; D007328:Insulin / Q000378:metabolism; D008041:Linoleic Acids / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008460:Meat; D051379:Mice; D018482:Muscle, Skeletal / Q000378:metabolism; D020033:Protein Isoforms / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism; D051381:Rats
D000970:Antineoplastic Agents; D007328:Insulin; D008041:Linoleic Acids; D020033:Protein Isoforms